huan wang

huan wang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2020 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
MMManuel Montalban-Lopez
Manuel Montalban-Lopez
TSThomas A. Scott
Thomas A. Scott
SRSangeetha Ramesh
Sangeetha Ramesh
IRImran R. Rahman
Imran R. Rahman
AHAuke J. van Heel
Auke J. van Heel
WDWilfred A. van der Donk
Wilfred A. van der Donk
This review provides a comprehensive update of the advances in discovery, biosynthesis, and engineering of ribosomally-synthesized and post-translationally modified peptides (RiPPs).

19 April 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
JTJian Tang
Jian Tang
YHYadong He
Yadong He
HCHongfei Chen
Hongfei Chen
WSWangjian Sheng
Wangjian Sheng
HWhuan wang
huan wang
Synthesis of cyclic peptides with novel Cβ–Ar crosslinks has been achieved by C(sp3)–H activation, and their biological properties have been evaluated for the first time.

8 June 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ZBZengbing Bai
Zengbing Bai
CCChuangxu Cai
Chuangxu Cai
WSWangjian Sheng
Wangjian Sheng
YRYuxiang Ren
Yuxiang Ren
HWhuan wang
huan wang

11 March 2023 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
NZNinglin Zhao
Ninglin Zhao
YSYingjie Song
Yingjie Song
XXXiangqian Xie
Xiangqian Xie
ZZZiqi Zhu
Ziqi Zhu
CDChenxi Duan
Chenxi Duan
RBRui Bao
Rui Bao
The fast-developing synthetic biology (SB) has provided many genetic tools to reprogram and engineer cells for improved performance, novel functions, and diverse applications. Such cell engineering resources can play a critical role in the research and development of novel therapeutics. However, there are certain limitations and challenges in applying genetically engineered cells in clinical practice. This literature review updates the recent advances in biomedical applications, including diagnosis, treatment, and drug development, of SB-inspired cell engineering. It describes technologies and relevant examples in a clinical and experimental setup that may significantly impact the biomedicine field. At last, this review concludes the results with future directions to optimize the performances of synthetic gene circuits to regulate the therapeutic activities of cell-based tools in specific diseases.

28 August 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ZBZengbing Bai
Zengbing Bai
CCChuangxu Cai
Chuangxu Cai
ZYZonglun Yu
Zonglun Yu
HWhuan wang
huan wang

23 August 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JTJian Tang
Jian Tang
HCHongfei Chen
Hongfei Chen
YHYadong He
Yadong He
WSWangjian Sheng
Wangjian Sheng
QBQingqing Bai
Qingqing Bai
HWhuan wang
huan wang
Peptides and peptidomimetics are emerging as an important class of clinic therapeutics. Here we report a peptide-guided method for the functionalization and macrocyclization of bioactive peptidosulfonamides by Pd(II)-catalyzed late-stage C–H activation. In this protocol, peptides act as internal directing groups and enable site-selective olefination of benzylsulfonamides and cyclization of benzosulfonamides to yield benzosultam-peptidomimetics. Our results provide an unusual example of benzosulfonamide cyclization with olefins through a sequential C–H activation, which involves the generation of a reactive palladium-peptide complex. Furthermore, this protocol allows facile self-guided macrocyclization of sulfonamide-containing peptides by intramolecular olefination with acrylates and unactivated alkenes, affording bioactive peptidosulfonamide macrocycles of various sizes. Together, our results highlight the utility of peptides as internal directing groups in facilitating transition metal-catalyzed functionalization of peptidomimetics.